Loading...
Infliximab-Associated Psoriasiform Dermatitis: Case Report and Review of a Seemingly Paradoxical Inflammatory Response
Background: Tumor necrosis factor-α (TNF-α) inhibitors, such as infliximab, adalimumab, and certolizumab pegol are effective agents in the treatment of inflammatory bowel disease. Some individuals undergoing anti-TNF-α therapy for Crohn’s disease or ulcerative colitis develop psoriasiform lesions. T...
Na minha lista:
| Udgivet i: | Cureus |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cureus
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5059146/ https://ncbi.nlm.nih.gov/pubmed/27738572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.773 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|